Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Drug Discovery and Translational Medicine

  • You have access
    Identification of glucose transport modulators in vitro and method for their deep learning neural network behavioral evaluation in Glut1 deficient mice
    Gauri Kathote, Qian Ma, Gustavo Angulo, Hong Chen, Vikram Jakkamsetti, Aksharkumar Dobariya, Levi B. Good, Bruce Posner, Jason Y. Park and Juan M. Pascual
    Journal of Pharmacology and Experimental Therapeutics January 12, 2023, JPET-AR-2022-001428; DOI: https://doi.org/10.1124/jpet.122.001428
  • Open Access
    Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma
    Floriane Lignet, Christina Esdar, Gina Walter-Bausch, Manja Friese-Hamim, Sofia Stinchi, Elise Drouin, Samer El Bawab, Andreas D. Becker, Claude Gimmi, Michael P. Sanderson and Felix Rohdich
    Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 163-172; DOI: https://doi.org/10.1124/jpet.122.001355
  • You have access
    The Novel, Clinical Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
    Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln, Hongxing Chen, Peng Sun, Jon Hill, Hu Sheng Qian, Mark McHugh, Holly Clifford, Khing Jow Ng, Hong Wang, Danielle Fowler, Kristina K. Gueneva-Boucheva, Todd Bosanac, Diane Wong, Ryan M. Fryer, Chris Sarko, Carine M Boustany-Kari and Steven S. Pullen
    Journal of Pharmacology and Experimental Therapeutics December 6, 2022, JPET-AR-2022-001423; DOI: https://doi.org/10.1124/jpet.122.001423
  • You have access
    The effects of dual GLP-1/GCG receptor agonists with different receptor selectivity in mouse models of obesity and NASH
    Ashref Kayed, Simone Anna Melander, Suheb Khan, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
    Journal of Pharmacology and Experimental Therapeutics November 23, 2022, JPET-AR-2022-001440; DOI: https://doi.org/10.1124/jpet.122.001440
  • You have access
    Pharmacodynamic and Antitumor Activity of BI 836880, a Dual VEGF and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
    Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg and Klaus-Peter Künkele
    Journal of Pharmacology and Experimental Therapeutics October 14, 2022, JPET-AR-2022-001255; DOI: https://doi.org/10.1124/jpet.122.001255
  • A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin
    You have access
    A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin
    Lucie Holá, Blanka Železná, Alena Karnošová, Jaroslav Kuneš, Jean-Alain Fehrentz, Séverine Denoyelle, Sonia Cantel, Miroslava Blechová, David Sýkora, Aneta Myšková and Lenka Maletínská
    Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 129-136; DOI: https://doi.org/10.1124/jpet.122.001322
  • Open Access
    Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
    Antonietta Franco, Xiawei Dang, Lihong Zhang, Perry B. Molinoff and Gerald W. Dorn
    Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 137-148; DOI: https://doi.org/10.1124/jpet.122.001332
  • You have access
    Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications
    Shiva Hadi Esfahani, Srinidhi Jayaraman and Vardan T. Karamyan
    Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 149-156; DOI: https://doi.org/10.1124/jpet.122.001339
  • Open Access
    Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia
    Anna Zuk, Zhihai Si, Sally Loi, Santhosh Bommegowda, Debie Hoivik, Sanjay Danthi, Gyongyi Molnar, Vilmos Csizmadia and Michael Rabinowitz
    Journal of Pharmacology and Experimental Therapeutics October 2022, 383 (1) 11-24; DOI: https://doi.org/10.1124/jpet.122.001126
  • You have access
    Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese Mice
    Peng Sun, Christina S. Bartlett, Chao Zheng, Tammy Bigwarfe, Joshuaine M. Grant, Margit MacDougall, Valentina Berger, Steven Kerr, Hu Sheng Qian, Mark McHugh, Hongxing Chen, Xiaomei Zhang, Miranda L. Carpenter, Heather N. Robinson, John Miglietta, Thorsten Lamla and Ryan M. Fryer
    Journal of Pharmacology and Experimental Therapeutics September 2022, 382 (3) 266-276; DOI: https://doi.org/10.1124/jpet.121.001067

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 51
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics